Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1997 Feb;34(2):169–172. doi: 10.1136/jmg.34.2.169

Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity.

A Pandya 1, X Xia 1, J Radnaabazar 1, J Batsuuri 1, B Dangaansuren 1, N Fischel-Ghodsian 1, W E Nance 1
PMCID: PMC1050876  PMID: 9039999

Abstract

Irreversible hearing loss is a catastrophic complication of treatment with aminoglycoside antibiotics such as streptomycin, gentamycin, and kanamycin. Many kindreds showing a matrilineal pattern of inheritance of this trait have been described in China where the widespread use of aminoglycoside antibiotics accounts for approximately 25% of profound deafness in some districts. Because of the characteristic inheritance pattern, mitochondrial DNA (mtDNA) mutations were postulated to be the cause of the deafness in these pedigrees. In 1993 it was shown that an A to G substitution at base pair 1555 of the mitochondrial 12S ribosomal RNA gene was the only mutation common to all the families with aminoglycoside ototoxicity. We ascertained three Mongolian pedigrees from the School for the Deaf and Blind in Ulaanbaatar, all of which contained multiple affected subjects with streptomycin induced deafness in a pattern consistent with matrilineal transmission. Amplified mtDNA, obtained from transformed lymphoblastoid cell lines using previously described primers, showed the A to G point mutation in the 12S rRNA gene in two of the three families by restriction analysis as well as direct sequencing. No other example of this substitution was found among 400 control samples from Mongolians with normal hearing. We have thus confirmed the clinical relevance of the 1555 A to G mitochondrial mutation in the 12S rRNA gene by identifying it in affected subjects with familial aminoglycoside ototoxicity in another ethnic group. In countries where aminoglycosides are widely used, genetic counselling and screening of high risk families before the use of these drugs could have a dramatic effect on the incidence of deafness.

Full text

PDF
171

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S., Bankier A. T., Barrell B. G., de Bruijn M. H., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F. Sequence and organization of the human mitochondrial genome. Nature. 1981 Apr 9;290(5806):457–465. doi: 10.1038/290457a0. [DOI] [PubMed] [Google Scholar]
  2. DeSalle R., Williams A. K., George M. Isolation and characterization of animal mitochondrial DNA. Methods Enzymol. 1993;224:176–204. doi: 10.1016/0076-6879(93)24015-m. [DOI] [PubMed] [Google Scholar]
  3. Fischel-Ghodsian N., Prezant T. R., Bu X., Oztas S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol. 1993 Nov-Dec;14(6):399–403. doi: 10.1016/0196-0709(93)90113-l. [DOI] [PubMed] [Google Scholar]
  4. Higashi K. Unique inheritance of streptomycin-induced deafness. Clin Genet. 1989 Jun;35(6):433–436. [PubMed] [Google Scholar]
  5. Jaber L., Shohat M., Bu X., Fischel-Ghodsian N., Yang H. Y., Wang S. J., Rotter J. I. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J Med Genet. 1992 Feb;29(2):86–90. doi: 10.1136/jmg.29.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Prezant T. R., Agapian J. V., Bohlman M. C., Bu X., Oztas S., Qiu W. Q., Arnos K. S., Cortopassi G. A., Jaber L., Rotter J. I. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993 Jul;4(3):289–294. doi: 10.1038/ng0793-289. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES